Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


'The referral service is a step towards greater clinical recognition'

C+D's editor gives his initial take on the rollout of the latest advanced service for England's community pharmacies to deliver

The new funding contract has understandably received a mix reaction from pharmacies since it was announced in July. Many have decried freezing funding for five years at a reduced level that is already proving unsustainable to run a business and cater to the needs of patients, while others have welcomed the stability needed to plan for the future.

While it certainly didn’t live up to the repeated government promises of “sustainable” funding after three years of cuts, it did at least offer a roadmap for how NHS England would like to better utilise the sector. The new focus on services will see certain pharmacies deliver hepatitis C screening, and potentially identify undiagnosed cardiovascular disease, undertake smoking cessation referrals from primary care, conduct discharge medication reviews and oversee expanded new medicine service consultations.

But top of the agenda was a national referral service from NHS 111.

The accompanying £14 consultation fee, while welcome, will hardly be a panacea for the financial woes suffered by so many of England’s pharmacies – especially if estimates of just one or two consultations a week at the outset prove to be accurate. However, as the number of referrals grows, so – hopefully – will community pharmacy’s reputation among both patients and the wider NHS as a source of clinical expertise. This is even more likely if referrals from GPs – currently being piloted – are added to the service as planned.

Pharmacists have correctly complained for years that their experience and training is rarely recognised, or fully utilised, by primary care and beyond. Let’s hope that this new national service is a step in the right direction.

James Waldron is editor of C+D. Let him know how your pharmacy is coping in 2019 by tweeting him @CandDJamesW or emailing him at [email protected]


Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts